临床试验

Cephea South America Feasibility Study

NCT：NCT07244939 · ACTIVE_NOT_RECRUITING

NCT编号NCT07244939

状态ACTIVE_NOT_RECRUITING

开始日期2025-06-17

SponsorAbbott Medical Devices (INDUSTRY)

First posted2025-11-24

Last updated2026-09-11

简要摘要

The objective of this study is to evaluate the preliminary safety and effectiveness of the Cephea Mitral Valve System for the treatment of symptomatic patients with mitral valve disease (including mitral regurgitation, mitral stenosis and mixed mitral valve disease) in whom transcatheter therapy is deemed more appropriate than open heart surgery.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。